2019 annual financial data

Corbus Pharmaceuticals Holdings 2019 Operating margin

Corbus Pharmaceuticals Holdings 2019 operating margin with verified reported va…

Direct answer

Operating margin was -213.33%.

Operating income was -77,104,579 USD and net income was -71,453,718 USD.
Operating cash flow was -45,720,728 USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
36,143,568 USD
Operating income
-77,104,579 USD
Net income
-71,453,718 USD
Operating cash flow
-45,720,728 USD